肝硬化合并难治性肝腹水的临床疗效观察

To Observe the Clinical Efficacy of Liver Cirrhosis with Refractory Ascites

目的探讨肝硬化顽固性腹水的临床特点以及治疗效果。方法将2011年6月至2012年10月我院诊治的60例肝硬化难治性腹水患者随机分为常规治疗组和腹水超滤浓缩回输治疗组,观察两组临床疗效。结果常规治疗组总有效率达70%,腹水超滤浓缩回输治疗组总有效率达90%,两组总有效率比较,有显著性差异(P<0.05)。结论应用腹水超滤浓缩回输等综合疗法治疗顽固性腹水,安全、简单、高效、疗效显著,值得临床推广。

Objective To investigate the clinical characteristics and treatment of liver cirrhosis with refractory ascites. Methods From June 2011 to October 2012 in our hospital 60 cases of liver cirrhosis and refractory ascites were randomly divided into conventional treatment group and ascites reinfusion treatment group, to observe the clinical curative effect of the two groups. Results The general effective rate of treatment group was 70%, the ascites reinfusion ultrafiltration treatment group, the total effective rate was 90%, the total efficiency of two groups, there were significant differences （P〈0.05）. Conclusion The application of ultmfiltration and reinfusion ofascites and other comprehensive therapy in the treatment of intractable ascites, safety, simple, efficient, obviously, is worth the clinical promotion.